Clinical trial
Treatment of Supine Hypertension in Autonomic Failure
NCT00223717 · Vanderbilt University, Other · Completed
Key facts
| NCT number | NCT00223717 |
|---|---|
| Title | Treatment of Supine Hypertension in Autonomic Failure |
| Official title | The Pathophysiology and Treatment of Supine Hypertension in Patients With Autonomic Failure |
| Lead sponsor | Vanderbilt University, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Dietary Supplement, Drug, Other |
| Interventions | Clonidine, Nitroglycerin transdermal, Dipyridamole/ Aspirin (Aggrenox), Desmopressin (DDAVP), Sildenafil, Nifedipine, Hydralazine, Hydrochlorothiazide, Placebo, Bosentan and 14 more |
| Enrollment | 152 |
| Start date | Jan 1, 2001 |
| Primary completion | Jan 1, 2017 |
| Completion | Jan 1, 2017 |
| First posted | Sep 22, 2005 |
| Last update posted | Oct 13, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: